rcps08-2005.
12 Sep 2017 In a note to investors, Cowen and Company analyst Doug Schenkel pointed out that the earlier recommendations, which extended the screening interval to five years if both pap smears and HPV testing were performed, "led to a notable decline in cytology revenue" for Hologic and Becton Dickinson, two
On September 12, 2017, the U.S. Preventive Services Task Force (USPSTF) released its draft cervical cancer screening recommendations and evidence review for public comment. The draft recommendations for average-risk women are listed in the following table. The major proposed change from the previous USPSTF
The USPSTF recommends screening for cervical cancer in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years.
18 Apr 2017 The USPSTF found good evidence from multiple observational studies that screening with cervical cytology (Pap smears) reduces incidence of and mortality from cervical cancer. New American Cancer Society (ACS) recommendations suggest stopping cervical cancer screening at age 70. Screening is

6 Mar 2018 Women aged 21 to 65 should be screened with cytology (commonly known as Pap smear) every 3 years. The Task Force also recommends against cervical cancer screening using HPV testing in women younger than age 30.
The U.S. Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service, and an assessment of the balance.
12 Sep 2017 The US Preventive Services Task Force (USPSTF) has issued new draft recommendations for cervical cancer screening. The major change from their 2012 recommendation is that testing for high-risk strains of human papillomavirus (hrHPV) alone is now recommended as an alternative to cytology or
The USPSTF recommends screening for cervical cancer in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years.

Annons

The photo has no tags

March 2018